Search hospitals > Texas > Dallas
University of Texas Southwestern Medical Center
Claim this profileDallas, Texas 75390
Global Leader in High Blood Pressure
Global Leader in Cancer
Conducts research for Parotid Gland Cancer
Conducts research for Lung Cancer
Conducts research for Fibrosing Colonopathy
2260 reported clinical trials
223 medical researchers
Summary
University of Texas Southwestern Medical Center is a medical facility located in Dallas, Texas. This center is recognized for care of High Blood Pressure, Cancer, Parotid Gland Cancer, Lung Cancer, Fibrosing Colonopathy and other specialties. University of Texas Southwestern Medical Center is involved with conducting 2,260 clinical trials across 1,980 conditions. There are 223 research doctors associated with this hospital, such as David Miller, MD, Matthew Campbell, MD, Syed M. Kazmi, and Patrick Leavey, MD.Area of expertise
1High Blood Pressure
Global LeaderStage I
6MWD
CTD-ILD
2Cancer
Global LeaderStage IV
Stage III
PIK3CA positive
Top PIs
David Miller, MDParkland Memorial Hospital2 years of reported clinical research
Expert in Parotid Gland Cancer
Studies Cervical Adenocarcinoma
21 reported clinical trials
40 drugs studied
Matthew Campbell, MDUT Southwestern/Simmons Cancer Center-Dallas3 years of reported clinical research
Studies Parotid Gland Cancer
Studies Bladder Cancer
19 reported clinical trials
36 drugs studied
Syed M. KazmiUT Southwestern/Simmons Cancer Center-Dallas7 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
17 reported clinical trials
33 drugs studied
Patrick Leavey, MDUT Southwestern/Simmons Cancer Center-Dallas4 years of reported clinical research
Studies Cancer
Studies Relapse
16 reported clinical trials
34 drugs studied
Clinical Trials running at University of Texas Southwestern Medical Center
Bladder Cancer
Breast Cancer
Kidney Cancer
Multiple Myeloma
Colorectal Cancer
Non-Small Cell Lung Cancer
Cystic Fibrosis
Chronic Lymphocytic Leukemia
Glioblastoma
Brain Tumor
FF-10832 + Pembrolizumab
for Cancer
To confirm a recommended Phase 2 dose (RP2D) of FF-10832 (Gemcitabine Liposome Injection) given intravenously Day 1 of a 21-day cycle, in combination with 200 mg pembrolizumab given intravenously Day 1 of the same 21-day cycle, for treatment of advanced urothelial and non-small cell lung cancer
Recruiting3 awards Phase 2
Disitamab Vedotin + Pembrolizumab vs Chemotherapy
for Bladder Cancer
This study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through the body (ureter, urethra). This study will try to find out if the drugs disitamab vedotin with pembrolizumab works better than platinum-containing chemotherapy to treat patients with UC. This study will also test what side effects happen when participants take these drugs together. A side effect is anything a drug does to the body besides treating the disease. Participants in this study will have cancer that has spread through the body (metastatic) or spread near where it started (locally advanced). In this study, there are 2 different groups. Participants will be assigned to a group randomly. Participants in the disitamab vedotin arm will get the study drug disitamab vedotin once every two weeks and pembrolizumab once every 6 weeks. Participants in the standard of care arm will get gemcitabine once a week for 2 weeks with either cisplatin or carboplatin once every 3 weeks.
Recruiting2 awards Phase 3
TAR-200 vs Chemotherapy
for Bladder Cancer
The purpose of this study is to compare disease free survival (DFS) in participants with recurrence of papillary-only high-risk non-muscle-invasive bladder cancer (HR-NMIBC) within 1 year of last dose of Bacillus Calmette-Guérin (BCG) therapy and who refused or are unfit for Radical Cystectomy (RC), receiving TAR-200 versus investigator's choice of single agent intravesical chemotherapy.
Recruiting2 awards Phase 32 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Texas Southwestern Medical Center?
Where is University of Texas Southwestern Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Texas Southwestern Medical Center accept?
What awards or recognition has University of Texas Southwestern Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.